SPLENDRIS - Trademark Details
Status: 700 - Registered
Serial Number
90389507
Registration Number
6559649
Word Mark
SPLENDRIS
Status
700 - Registered
Status Date
2021-11-16
Filing Date
2020-12-17
Registration Number
6559649
Registration Date
2021-11-16
Mark Drawing
5000 - Illustration: Drawing with word(s)/letter(s)/number(s) in Stylized form
Typeset
Published for Opposition Date
2021-08-31
Attorney Name
Law Office Assigned Location Code
N30
Employee Name
MURRAY, GEORGE WILLIAM
Statements
Description of Mark
The mark consists of the literal element "SPLENDRIS" in stylized font.
Goods and Services
Pharmaceutical preparations, for treating diseases of cardiovascular system, for treating diseases of cerebrovascular system, for use in haematology, dermatology, ophthalmology and gastroenterology, anti-infectives, antitumor drugs, for treating metabolic diseases, for treating nervous system diseases, for treating diseases of respiratory system, digestive system, endocrine system, immune system and musculo-skeletal system, and for treating hypersensitivity diseases; Chemico-pharmaceutical preparations, for treating diseases of cardiovascular system, for treating diseases of cerebrovascular system, for use in haematology, dermatology, ophthalmology and gastroenterology, anti-infectives, antitumor drugs, for treating metabolic diseases, for treating nervous system diseases, for treating diseases of respiratory system, digestive system, endocrine system, immune system and musculo-skeletal system, and for treating hypersensitivity diseases; Chemical preparations for pharmaceutical or medical purposes, namely, for treating diseases of cardiovascular system, for treating diseases of cerebrovascular system, for use in haematology, dermatology, ophthalmology and gastroenterology, anti-infectives, antitumor drugs, for treating metabolic diseases, for treating nervous system diseases, for treating diseases of respiratory system, digestive system, endocrine system, immune system and musculo-skeletal system, and for treating hypersensitivity diseases; Medicines for human purpose, for treating diseases of cardiovascular system, for treating diseases of cerebrovascular system, for use in haematology, dermatology, ophthalmology and gastroenterology, anti-infectives, antitumor drugs, for treating metabolic diseases, for treating nervous system diseases, for treating diseases of respiratory system, digestive system, endocrine system, immune system and musculo-skeletal system, and for treating hypersensitivity diseases; Medicated Troches, for the prevention and treatment of disorders of the nervous system, the immune system, the cardiovascular system, the cerebrovascular system, the metabolic system, the respiratory system, the musculo-skeletal system, digestive system, endocrine system, for the treatment of infective diseases, for use in dermatology, oncology, hematology and in tissue and organ transplantation, in ophthalmology and for gastroenterological disorders; Active pharmaceutical ingredients in the nature of pharmaceutical preparations, which are used for the prevention and treatment of disorders of the nervous system, the immune system, the cardiovascular system, the cerebrovascular system, the metabolic system, the respiratory system, the musculo-skeletal system, digestive system, endocrine system, for the treatment of infective diseases, for use in dermatology, oncology, hematology and in tissue and organ transplantation, in ophthalmology and for gastroenterological disorders; Medicinal herbal preparations, for treating diseases of cardiovascular system, for treating diseases of cerebrovascular system, for use in haematology, dermatology, ophthalmology and gastroenterology, anti-infectives, antitumor drugs, for treating metabolic diseases, for treating nervous system diseases, for treating diseases of respiratory system, digestive system, endocrine system, immune system and musculo-skeletal system, and for treating hypersensitivity diseases; Biochemical medicines, for treating diseases of cardiovascular system, for treating diseases of cerebrovascular system, for use in haematology, dermatology, ophthalmology and gastroenterology, anti-infectives, antitumor drugs, for treating metabolic diseases, for treating nervous system diseases, for treating diseases of respiratory system, digestive system, endocrine system, immune system and musculo-skeletal system, and for treating hypersensitivity diseases, Pharmaceutical preparations for the treatment of heart rhythm disorders, Synthetic peptides for the treatment of cardiovascular disease; Dietetic substances adapted for medical use, namely, beverages and food in the nature of vitamin, protein, minerals, lecithin, glucose, amino acid, folic acid, fruit juice, fruit oil, honey, seaweed glue, fish oil, cod-liver oil, cubilose, restoratives, plant fibre, nutrition powder, nutrient capsule, nutrient tablets, mineral food-supplements used for treating diseases of cardiovascular system, for treating diseases of cerebrovascular system, for use in haematology, dermatology, ophthalmology and gastroenterology, anti-infectives, antitumor drugs, for treating metabolic diseases, for treating nervous system diseases, for treating diseases of respiratory system, digestive system, endocrine system, immune system and musculo-skeletal system, and for treating hypersensitivity diseases; Drugs for medical purposes, namely, Pharmaceutical products for the prevention and treatment of disorders of the nervous system, the immune system, the cardiovascular system, the cerebrovascular system, the metabolic system, the respiratory system, the musculo-skeletal system, digestive system, endocrine system, for the treatment of infective diseases, for use in dermatology, oncology, hematology and in tissue and organ transplantation, in ophthalmology and for gastroenterological disorders
Translation of Words in Mark
The wording "SPLENDRIS" has no meaning in a foreign language.
Classification Information
International Class
005 - Pharmaceutical, veterinary and sanitary preparations; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. - Pharmaceutical, veterinary and sanitary preparations; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes
005, 006, 018, 044, 046, 051, 052
Class Status Code
6 - Active
Class Status Date
2021-02-26
Primary Code
005
Current Trademark Owners
Party Type
30 - Original Registrant
Legal Entity Type
99 - Other (limited company (ltd.)).
Address
Please log in with your Justia account to see this address.
Trademark Owner History
Party Type
30 - Original Registrant
Legal Entity Type
99 - Other (limited company (ltd.)).
Address
Please log in with your Justia account to see this address.
Party Type
20 - Owner at Publication
Legal Entity Type
99 - Other (limited company (ltd.)).
Address
Please log in with your Justia account to see this address.
Party Type
10 - Original Applicant
Legal Entity Type
99 - Other (limited company (ltd.)).
Address
Please log in with your Justia account to see this address.
Correspondences
Name
Nazly Aileen Bayramoglu
Address
Please log in with your Justia account to see this address.
Prior Registrations
Relationship Type | Reel Number |
Prior Registration | 4642937 |
Foreign Application Information
Filing Date | Application Number | Country | Foreign Priority Claim In |
China P.Rep. | False | ||
False |
Trademark Events
Event Date | Event Description |
2020-12-21 | NEW APPLICATION ENTERED IN TRAM |
2021-02-26 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM |
2021-06-11 | ASSIGNED TO EXAMINER |
2021-06-16 | NON-FINAL ACTION WRITTEN |
2021-06-16 | NON-FINAL ACTION E-MAILED |
2021-06-16 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
2021-07-21 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
2021-07-21 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
2021-07-22 | TEAS/EMAIL CORRESPONDENCE ENTERED |
2021-07-28 | APPROVED FOR PUB - PRINCIPAL REGISTER |
2021-08-11 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
2021-08-31 | PUBLISHED FOR OPPOSITION |
2021-08-31 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
2021-11-16 | REGISTERED-PRINCIPAL REGISTER |